Zenas BioPharma (ZBIO) Shares Outstanding (Weighted Average) (2023 - 2026)

Zenas BioPharma's Shares Outstanding (Weighted Average) history runs 4 years deep, the most recent figure standing at $55.6 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) rose 33.07% year-over-year to $55.6 million; the TTM figure through Mar 2026 stood at $55.6 million (up 33.07% YoY), while the FY2025 annual figure was $44.7 million, up 238.89% from the prior year.
• Shares Outstanding (Weighted Average) was $55.6 million for Q1 2026 at Zenas BioPharma, up from $44.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $55.6 million in Q1 2026 to a low of $1.5 million in Q4 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $23.0 million across 4 years, with a median of $13.2 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Shares Outstanding (Weighted Average) jumped 2589.73% in 2025, then surged 33.07% in 2026.
• A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $1.5 million in 2023, then surged by 762.01% to $13.2 million in 2024, then jumped by 238.89% to $44.7 million in 2025, then climbed by 24.36% to $55.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $55.6 million (Q1 2026), $44.7 million (Q4 2025), and $41.9 million (Q3 2025), per Business Quant data.